Johnson & Johnson said Oct. 12 it appointed Jessica Moore as vice president of investor relations, effective Nov. 1.
With 20 years of strong, diverse and international financial experience spanning sales operations, corporate and regional positions, Moore most recently served as the vice president and chief financial officer for the Janssen Pharmaceutical business in the EMEA Region where she played a critical role in the analysis of financial performance, assessment of risks and opportunities and maintenance of a strong compliant environment.
Moore will report to Joseph Wolk, executive vice president and CFO of the company.
Prior to joining Johnson & Johnson, she held various leadership positions of increasing responsibilities at Baxter International, where she focused on returning the EMEA business to growth, and led a project to standardize and centralize financial processes across commercial and manufacturing entities.
“Jessica’s knowledge of our business and industries positions her well to convey Johnson & Johnson’s strategies and outcomes to the investment community and other key stakeholders,” said Wolk in a prepared statement. “Her dedication to innovative solutions and commitment to talent development will have a positive impact across all aspects of our business.”